News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
727,614 Results
Type
Article (44001)
Company Profile (312)
Press Release (683301)
Multimedia
Podcasts (73)
Webinars (13)
Section
Business (211866)
Career Advice (2097)
Deals (36396)
Drug Delivery (100)
Drug Development (82297)
Employer Resources (176)
FDA (16735)
Job Trends (15322)
News (356153)
Policy (33415)
Tag
Academia (2708)
Accelerated approval (5)
Adcomms (20)
Allergies (89)
Alliances (52468)
ALS (90)
Alzheimer's disease (1403)
Antibody-drug conjugate (ADC) (135)
Approvals (16736)
Artificial intelligence (284)
Autoimmune disease (22)
Automation (16)
Bankruptcy (365)
Best Places to Work (11930)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (221)
Bladder cancer (80)
Brain cancer (27)
Breast cancer (282)
Cancer (2292)
Cardiovascular disease (178)
Career advice (1756)
Career pathing (31)
CAR-T (159)
Cell therapy (440)
Cervical cancer (19)
Clinical research (66789)
Collaboration (869)
Company closure (1)
Compensation (554)
Complete response letters (19)
COVID-19 (2676)
CRISPR (45)
C-suite (251)
Cystic fibrosis (104)
Data (2235)
Decentralized trials (2)
Denatured (30)
Depression (44)
Diabetes (273)
Diagnostics (6639)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (124)
Drug pricing (102)
Drug shortages (27)
Duchenne muscular dystrophy (94)
Earnings (88279)
Editorial (37)
Employer branding (22)
Employer resources (151)
Events (117166)
Executive appointments (748)
FDA (18027)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (781)
Gene editing (114)
Generative AI (26)
Gene therapy (317)
GLP-1 (729)
Government (4518)
Grass and pollen (5)
Guidances (67)
Healthcare (19537)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (117)
Indications (30)
Infectious disease (2821)
Inflammatory bowel disease (141)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (100)
Interviews (323)
IPO (16851)
IRA (41)
Job creations (3819)
Job search strategy (1494)
Kidney cancer (10)
Labor market (38)
Layoffs (481)
Leadership (18)
Legal (8128)
Liver cancer (77)
Lung cancer (324)
Lymphoma (156)
Machine learning (7)
Management (62)
Manufacturing (313)
MASH (68)
Medical device (14112)
Medtech (14117)
Mergers & acquisitions (20102)
Metabolic disorders (696)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (90)
Neuropsychiatric disorders (27)
Neuroscience (1945)
NextGen: Class of 2025 (6844)
Non-profit (4618)
Now hiring (39)
Obesity (367)
Opinion (217)
Ovarian cancer (75)
Pain (88)
Pancreatic cancer (84)
Parkinson's disease (150)
Partnered (21)
Patents (242)
Patient recruitment (113)
Peanut (49)
People (59534)
Pharmaceutical (69)
Pharmacy benefit managers (18)
Phase I (20962)
Phase II (29385)
Phase III (21812)
Pipeline (1213)
Policy (141)
Postmarket research (2582)
Preclinical (8996)
Press Release (71)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (265)
Rare diseases (384)
Real estate (6235)
Recruiting (65)
Regulatory (22867)
Reports (46)
Research institute (2459)
Resumes & cover letters (361)
Rett syndrome (5)
RNA editing (5)
RSV (43)
Schizophrenia (71)
Series A (137)
Series B (86)
Service/supplier (15)
Sickle cell disease (53)
Special edition (14)
Spinal muscular atrophy (148)
Sponsored (30)
Startups (3841)
State (2)
Stomach cancer (13)
Supply chain (69)
Tariffs (40)
The Weekly (41)
Vaccines (722)
Venture capitalists (42)
Weight loss (240)
Women's health (36)
Worklife (16)
Date
Today (27)
Last 7 days (926)
Last 30 days (2554)
Last 365 days (33467)
2025 (11044)
2024 (36219)
2023 (41136)
2022 (52397)
2021 (56994)
2020 (55612)
2019 (48407)
2018 (36441)
2017 (33541)
2016 (33139)
2015 (39358)
2014 (32941)
2013 (27985)
2012 (30243)
2011 (30847)
2010 (28809)
Location
Africa (759)
Alabama (54)
Alaska (7)
Arizona (241)
Arkansas (14)
Asia (40520)
Australia (6739)
California (6265)
Canada (2035)
China (537)
Colorado (273)
Connecticut (285)
Delaware (155)
Europe (88680)
Florida (920)
Georgia (216)
Idaho (60)
Illinois (560)
India (26)
Indiana (316)
Iowa (11)
Japan (165)
Kansas (107)
Kentucky (25)
Louisiana (11)
Maine (62)
Maryland (906)
Massachusetts (4721)
Michigan (241)
Minnesota (403)
Mississippi (2)
Missouri (88)
Montana (30)
Nebraska (25)
Nevada (64)
New Hampshire (69)
New Jersey (1762)
New Mexico (28)
New York (1778)
North Carolina (1016)
North Dakota (9)
Northern California (2718)
Ohio (209)
Oklahoma (15)
Oregon (37)
Pennsylvania (1396)
Puerto Rico (13)
Rhode Island (34)
South America (1154)
South Carolina (23)
South Dakota (1)
Southern California (2353)
Tennessee (103)
Texas (924)
United States (23742)
Utah (188)
Virginia (150)
Washington D.C. (63)
Washington State (571)
West Virginia (3)
Wisconsin (57)
727,614 Results for "biorem technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biorem Reports Record Revenues and Earnings before tax for 2024 and Again Reports Record Order Backlog
April 16, 2025
·
4 min read
Press Releases
Biorem Reports Second Quarter Results with 77% Increase in Year over Year Revenue and Record Order Backlog
August 26, 2024
·
3 min read
Business
Biorem Reports Second Quarter Results and Record Order Backlog
BIOREM Inc. today announced its results for the three and six-month periods ended June 30, 2023.
August 23, 2023
·
3 min read
Business
Biorem Reports Record 2022 Financial Results
BIOREM Inc. (TSXV: BRM) (“Biorem” or “the Company”) today announced its results for the three and twelve-month periods ended December 31, 2022.
April 5, 2023
·
4 min read
Business
Biorem Reports First Quarter Financial Results - May 24, 2023
BIOREM Inc. today announced results for the three month period ended March 31, 2023.
May 24, 2023
·
3 min read
BIOREM order backlog exceeds $50 million on strength of $11-million in new orders
BIOREM Inc. announced $10.6 million of new orders for air emission abatement projects in North America.
June 6, 2023
·
3 min read
Deals
Biorem Announces Stock Option Grant - June 9, 2023
Biorem Inc. announces that, pursuant to its incentive Stock Option Plan, it has granted incentive stock options to certain directors, of the Company to purchase up to an aggregate of 50,000 common shares in the capital stock of the Company.
June 9, 2023
·
1 min read
Press Releases
Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology
April 16, 2025
·
4 min read
Business
Biorem Reports Third Quarter Results & Increases in Revenues and Earnings
GUELPH, ON, Nov. 15, 2022 /PRNewswire/ - BIOREM Inc. announced its results for the three and nine-month periods ended September 30, 2022.
November 15, 2022
·
3 min read
Press Releases
FOXO TECHNOLOGIES INC. ANNOUNCES EXECUTION OF A NON BINDING AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.
March 20, 2025
·
4 min read
1 of 72,762
Next
